Inhibition of human UDP-Glucuronosyltransferase 1A (UGT1A) enzymes by three different Tyrosine Kinase Inhibitors (Lapatinib, Pazopanib and Sorafenib): implications for drug interactions and jaundice

Ganessan Kichenadasse; Andrew Rowland; John Miners

Inhibition of human UDP-Glucuronosyltransferase 1A (UGT1A) enzymes by three different Tyrosine Kinase Inhibitors (Lapatinib, Pazopanib and Sorafenib): implications for drug interactions and jaundice

Ganessan Kichenadasse, Andrew Rowland, John Miners

Research output: Contribution to conference › Paper › peer-review

Original language	English
Publication status	Published - 2012
Event	46th ASCEPT Annual Scientific Meeting - Duration: 2 Dec 2012 → …

Conference

Conference	46th ASCEPT Annual Scientific Meeting
Period	2/12/12 → …

Cite this

@conference{b6a35b01da5e486eb5648349368564c5,

title = "Inhibition of human UDP-Glucuronosyltransferase 1A (UGT1A) enzymes by three different Tyrosine Kinase Inhibitors (Lapatinib, Pazopanib and Sorafenib): implications for drug interactions and jaundice",

author = "Ganessan Kichenadasse and Andrew Rowland and John Miners",

year = "2012",

language = "English",

note = "46th ASCEPT Annual Scientific Meeting ; Conference date: 02-12-2012",

}

Inhibition of human UDP-Glucuronosyltransferase 1A (UGT1A) enzymes by three different Tyrosine Kinase Inhibitors (Lapatinib, Pazopanib and Sorafenib): implications for drug interactions and jaundice. / Kichenadasse, Ganessan ; Rowland, Andrew ; Miners, John.
2012. Paper presented at 46th ASCEPT Annual Scientific Meeting.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Inhibition of human UDP-Glucuronosyltransferase 1A (UGT1A) enzymes by three different Tyrosine Kinase Inhibitors (Lapatinib, Pazopanib and Sorafenib): implications for drug interactions and jaundice

AU - Kichenadasse, Ganessan

AU - Rowland, Andrew

AU - Miners, John

PY - 2012

Y1 - 2012

M3 - Paper

T2 - 46th ASCEPT Annual Scientific Meeting

Y2 - 2 December 2012

ER -